~~<i id='C34A78400E'><strike id='C34A78400E'><tt id='C34A78400E'><pre id='C34A78400E'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

comprehensive

author：fashion 2025-10-01 23:02:24 - browse：3

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Thursday approved the first medicine developed specifically to treat the serious liver disease known as MASH.

The pill, called Rezdiffra, is made by Madrigal Pharmaceuticals.

Metabolic dysfunction-associated steatohepatitis, or MASH, is often associated with obesity. The accumulation of fat in the liver causes inflammation, which leads to fibrosis, or liver scarring, and can progress in more advanced stages to cirrhosis, cancer, and the need for a liver transplant.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Ethical issues complicate the benefits of medical crowdfunding

hotspot

knowledge

Wikipedia

entertainment

Wikipedia

HumanembryonicstemcellsAnnieCavanagh/WellcomeImagesTheFoodandDrugAdministrationonThursdayunveiledase

WSS

Humana sues Biden admin over Medicare Advantage audit rule

House transparency, PBM reform bill gains bipartisan support

Copay coupons to count toward deductibles, after Biden court move

Medicare Advantage today, explained in one chart

FDA clears AI tool for detecting skin cancer

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

explore

comprehensive

hotspot

Affirmative action in medical school literally saved lives

How generative AI is inspiring dreams of a health data revolution

In Memoriam: Notable people who died in 2023

How to protect patients from sexual assault

At least 13 dead in Texas as scorching temps continue

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

DIEP, the 'gold standard' of breast reconstruction, is under threat

A rare thyroid diagnosis led to unexpected, all

Medicare details structure of new drug price negotiation program

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

knowledge

Why doctors need education on FDA device approval process

Biotech venture capitalists face new demands from investors

Francis Collins on trust in science and how Covid communications failed

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

A new House health package & hospitals’ new site

How to fix cancer clinical trials' diversity problem

Wikipedia

entertainment

Wikipedia

Wikipedia